21/46US=46 / Câncer
Bunger MK, Archer TK. Epigenetic mechanisms in tumorigenesis. In: Meyers RA. Cancer: from mechanisms to therapeutic approaches. New Jersey: Wiley-Blackwell, 2007. p. 115-53. ISBN 978-3-527-31768-4.

MECANISMOS EPIGENETICOS NA CARCINOGENESE; EPIGENETICA; HISTONAS; NUCLEOSOME; CROMATINA; HETEROCROMATINA; PERDA DE HETEROZIGOSE


22/46US=57-B / Biol/Mol
Weinberg RA. Eternal life: cell immortalization and tumorigenesis. In: ___. The biology of cancer. New York: Garland Science, 2007. p. 357-98. ISBN 0-8153-4078-8.

IMORTALIZACAO CELULAR; TUMORIGENESE; CELULAS CANCEROSAS IMORTAIS; CELULAS SENESCENTES IN VITRO; CELULAS SENESCENTES IN VIVO; EVIDENCIA DE CELULAS SENESCENTES; PROLIFERACAO DE CELULAS CANCEROSAS HUMANAS


23/46US=57-B / Biol/Mol
Weinberg RA. Multi-step tumorigenesis. In: ___. The biology of cancer. New York: Garland Science, 2007. p. 399-462. ISBN 0-8153-4078-8.

TUMORIGENESIS; PROGRESSAO TUMORAL; CANCER DE PULMAO. CONSUMO DE CIGARRO; CANCER EPITELIAIS; INCIDENCIA DE CANCER; EXPOSICAO CANCERIGENA; EVIDENCIA DE PROGRESSAO ADENOCARCINOMA; PROGRESSAO DO TUMOR DE COLON; GENES SUPRESSORES DE TUMORES; PROGRESSAO DO CARCINOMA DO COLON; ENRIQUECIMENTO DE CELULAS-TRONCO. CANCER DE MAMA


24/46US=92 / Biol/Mol
McConkey DJ, Bondar V. Telomeres and telomerase, senescence, genomic instabilidade, and tumorigenesis: structure and function of the telomere. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 125-44. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9.

TELOMERASE; ALT; TUMORIGENESIS; INSTABILIDADE GENOMICA; ESTABILIDADE CROMOSSOMO; CANCER; ENVELHECIMENTO


25/46US=92 / Biol/Mol
Ramirez RD. Telomeres and telomerase, senescence, genomic instabilidade, and tumorigenesis: overview of senescence. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 145-57. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9.

SENESCENCIA CELULAR; ENVELHECIMENTO; TELOMEROS; TELOMERASE; ALTERNATIVA PARA ALONGAR OS TELOMEROS; PROBLEMA DE REPLICACAO FINAL


26/46US=92 / Biol/Mol
Possemato R, Hahn WC. Telomeres and telomerase, senescence, genomic instabilidade, and tumorigenesis: contributions of telomerase to tumorigenesis. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 159-71. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9.

TRANSCRIPTASE REVERSA DA TELOMERASE; TELOMERO; TUMORIGENESIS; TRANSFORMACAO; CANCER


27/46US=92 / Biol/Mol
Murnane JP. Telomeres and telomerase, senescence, genomic instabilidade, and tumorigenesis: the role of telomeres in genomic instability. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 173-89. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9.

AMPLIFICACAO; FUSAO CROMOSSOMICA; ELIMINACAO; DUPLICACAO; INSTABILIDADE GENOMICA; ISOCHROMOSOME; TELOMERO; TRANSLOCACAO


28/46US=92 / Biol/Mol
Dupré A, Gautier J. DNA damage response, signalling pathways, and tumorigenesis: overview of the DNA damage checkpoint. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 193-221. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9.

ATM; ATR; CHECKPOINTS; REPLICA; CADEIA SIMPLES DE DNA; REPARO DE QUEBRA DE DUPLA FITA DO DNA


29/46US=92 / Biol/Mol
Maclean KH, Cleveland JL. DNA damage response, signalling pathways, and tumorigenesis: interactions between Myc- and cyclin-dependent kinase inhibitors in cancer. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 223-41. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9.

MYC; CDK; INIBIDORES DE CDK; INK4; CIP/KIP; CICLINA


30/46US=92 / Biol/Mol
Chronis F, Ragakou EP. DNA damage response, signalling pathways, and tumorigenesis: interplay between yH2AX and 53BP1 pathways in DNA double-strand break repair response. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 243-63. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9.

H2AX; 53BP1; REPARO DE DNA; QUEBRAS DE DUPLA VERTENTE; CROMATINA


31/46US=92 / Biol/Mol
Povirk LF. DNA damage response, signalling pathways, and tumorigenesis: DNA-dependent protein kinase in repair, apoptosis, telomere maintenance, and chemotherapy. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 265-78. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9.

ACABAR JUNTANDO RADIACAO; RUPTURAS DE FILAMENTOS DUPLOS; REPARO DO DNA; KU; ARTEMIS; REPARACAO FOCOS


32/46US=88 / Biol/Mol
Bernier-Latmani J, Shaw P. Imprinting alterations in tumorigenesis. In: Tollefsbol T. Cancer epigenetics. Boca Raton: CRC, 2009. p. 51-63. ISBN 978-1-4200-4579-6.

CANCER; EPIGENETICA; TUMORIGENESE; IMPRINTING GENOMICO; EXPRESSAO GENICA


33/46US=88 / Biol/Mol
Saldanha SN, Tollefsbol TO. Alterations in histone acetylation in tumorigenesis. In: Tollefsbol T. Cancer epigenetics. Boca Raton: CRC, 2009. p. 97-108. ISBN 978-1-4200-4579-6.

CANCER; EPIGENETICA; TUMORIGENESE; ACETILACAO DAS HISTONAS; NUCLEOSSOMOS


34/46US=88 / Biol/Mol
Zhang X, Hsieh TI, Nicosia SV, Bai W. Role of sirtuins in aging and tumorigenesis. In: Tollefsbol T. Cancer epigenetics. Boca Raton: CRC, 2009. p. 151-80. ISBN 978-1-4200-4579-6.

CANCER; EPIGENETICA; TUMORIGENESE; SIRTUINAS; ENVELHECIMENTO; HISTONAS DEACETYLASES


35/46US=88 / Biol/Mol
Niessen HEC, Voncken JW. Polycomb group proteins in tumorigenesis. In: Tollefsbol T. Cancer epigenetics. Boca Raton: CRC, 2009. p. 281-301. ISBN 978-1-4200-4579-6.

CANCER; EPIGENETICA; PROTEINAS DO GRUPO POLYCOMB; TUMORIGENESE; PCG


36/46US=2 / Biol/Mol
Naik E, Strasser A. Bcl-2 family: the role of the Bcl-2 protein family in tumorigenesis and cancer therapy. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 317-45. ISBN 978-3-527-31237-5.

FAMILIA BCL-2; TUMORIGENESE; CANCER. TERAPIA; MORTE CELULAR; APOPTOSE


37/46US=2 / Biol/Mol
Greten FR, Karin M. Survival pathways: nuclear factor-kB in apoptosis and tumorigenesis. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 443-61. ISBN 978-3-527-31237-5.

CANCER; FATOR NUCLEAR-KB; APOPTOSE; CARCINOGENESE


38/46US=2 / Biol/Mol
Ramadan S, Sayan E, Oberst A, Chikh A, Pietroni V, Rufini A, Melino G, Bernassola F. Oncogenes/tumor suppressor genes: p73 affects cell fate and tumorigenesis. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 536-50. ISBN 978-3-527-31237-5.

ONCOGENES; GENES SUPRESSORES TUMORAIS; P73; TUMORIGENESE


39/46US=16 / Tórax
Chen TMB, Kuschner WG. Etiology and epidemiology: non-tabacco-related lung carcinogenesis. In: Pass HL, Carbone DP, Johnson DH, Minna JD, Turrisi III AT. Lung Cancer: principles and practice. Philadelphia: Lippincott Williams & Wilkins, 2005. p. 61-73. ISBN 0-7817-4620-5.

CARCINOGENESE DO PULMAO; TUMORIGENESIS; TABACO; SUBSTANCIAS CANCERIGENAS RESPIRAVEIS; IDENTIFICACAO DAS SUBSTANCIAS CANCERIGENAS PULMONARES NAO-TABACO; ARSENICO; ASBESTOS; BERYLLIUM; ETER; CROMO; DIESEL; OLEO MINERAL; NIQUEL; RADONIO; SILICA; CLORETO DE VINIL


40/46US=630 / Tese/FAP
Sousa EA. Avaliação da transição epitélio-mesênquima durante a morfogênese e tumorigênese das glândulas salivares humanas. [Evaluation of epithelial-mesenchymal transition during the morphogenesis and tumorigenesis of human salivary glands]. São Paulo, 2017. 59 p. Tese(Doutorado)-Fundação Antônio Prudente.

Disponível em: http://accamargo.phlnet.com.br/Doutorado/2017/ElenASousa/ElenASousa.pdf

Curriculum Lattes

GLANDULAS SALIVARES; TRANSICAO EPITELIAL-MESENQUIMAL; CARCINOGENESE; MORFOGENESE


Primeira | Anterior | Próxima | Última